Effectiveness of erythromycin in the treatment of acute bronchitis

Journal of Family Practice

Volumn 42, Issue 6, 1996, Pages 601-605

  King, Dana E ^a,c   Williams, William Cameron ^b   Bishop, Lynn ^a   Shechter, Aaron ^a  

^a EAST CAROLINA UNIVERSITY   (United States)

^b Fam Med Associates of Lewisville   (United States)

^c EAST CAROLINA UNIVERSITY   (United States)

Author keywords

Bronchitis; erythromycin; pneumonia, mycoplasma; treatment outcome

Indexed keywords

ERYTHROMYCIN; PLACEBO;

ABSENTEEISM; ANTIBIOTIC THERAPY; ANTIBODY DETECTION; ARTICLE; BRONCHITIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; GASTROINTESTINAL SYMPTOM; HUMAN; MAJOR CLINICAL STUDY; MYCOPLASMA PNEUMONIAE; ORAL DRUG ADMINISTRATION; PATIENT SELECTION; RANDOMIZED CONTROLLED TRIAL;

ACUTE DISEASE; ADULT; ANTI-BACTERIAL AGENTS; BRONCHITIS; DOUBLE-BLIND METHOD; ERYTHROMYCIN; FEMALE; HUMANS; MALE; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 0029980825     PISSN: 00943509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Marsland DW, Wood M, Mayo F. Content of family practice: part I. Rank order of diagnosis by frequency. J Fam Pract 1976; 3:37-68.
2. Rosenblatt RA, Cherkin DC, Schneeweiss R, et al. The structure and content of family practice: current status and future trends. J Fam Pract 1982; 15:681-722.
3. Dunlay J, Reinhardt R. Clinical features and treatment of acute bronchitis. J Fam Pract 1984; 18:719-22.
4. Orr PH, Scherer K, Macdonald A, Moffatt MEK. Randomized placebo-controlled trials of antibiotics for acute bronchitis: a critical review of the literature. J Fam Pract 1993; 36:507-12.
5. Gwaltney JM. Acute bronchitis. In: Mandell GL, Douglas RG, Bennett JE, eds. Principles and practice of infectious diseases. New York, NY: Churchill Livingstone, 1990:529-31.
6. Medical research council working party on acute respiratory virus infections. A collaborative study on the aetiology of acute respiratory infections in Britain 1961-1964. BMJ 1965; 2:319-26.
7. Monto AS, Cavaliaro JJ. The Tecumseh study of respiratory illness: II. Patterns of occurrence of infection with respiratory pathogens, 1965-1967. Am J Epidemiol 1971; 94:280-9.
8. Verheij TJM, Kaptein AA, Mulder JO. Acute bronchitis: aetiology, symptoms and treatment. Fam Pract 1989; 6:66-9.
9. Ellner JJ. Management of acute and chronic respiratory tract infections. Am J Med 1988; 85(suppl 3A):2-5.
10. Laurenzi GA, Potter RT, Kass EH. Bacteriologic flora of the lower respiratory tract. N Engl J Med 1961; 265:1273-8.
11. Franks P, Gleiner JA. The treatment of acute bronchitis with trimethoprim and sulfamethoxazole. J Fam Pract 1984; 19:185-90.
12. Brickfield FX, Carter WH, Johnson RE. Erythromycin in the treatment of acute bronchitis in a community practice. J Fam Pract 1986; 23:119-22.
13. Stott NC, West RR. Randomized controlled trial of antibiotics in patients with cough and purulent sputum. BMJ 1976; 2:556-9.
14. Williamson HA Jr. A randomized, controlled trial of doxycycline in the treatment of acute bronchitis. J Fam Pract 1984; 19:481-6.
15. Dunlay J, Reinhardt R, Roi L. A placebo-controlled, double-blind trial of erythromycin in adults with acute bronchitis. J Fam Pract 1987; 25:137-41.
16. Denny FW, Clyde WA, Glezen WP. Mycoplasma pneumoniae disease: clinical spectrum, pathophysiology, epidemiology, and control. J Infect Dis 1971; 123:74-92.
17. Cassell GH, Cole BC. Mycoplasmas as agents in human disease. N Engl J Med 1981; 304:80-9.
18. Clyde WA. Mycoplasma pneumoniae respiratory disease symposium: summation and significance. Yale J Biol Med 1983; 56:523-7.
19. Grayston JT, Alexander ER, Kenny GE, et al. Mycoplasma pneumoniae infections. JAMA 1965; 191:97-102.
20. Evans AJ, Allen V, Sueltmann S. Mycoplasma pneumoniae infections in University of Wisconsin students. Am Rev Respir Dis 1967; 96:237-44.
21. Mogabgab WJ. Mycoplasma pneumoniae and adenovirus respiratory illnesses in military and university personnel, 1959-1966. Am Rev Respir Dis 1968; 97:345-58.
22. King DE, Muncie HL. High prevalence of Mycoplasma pneumoniae in patients with respiratory tract symptoms: a rapid detection method. J Fam Pract 1991; 32:529-31.
23. Rodnick JH, Gude JR. Pulmonary infections. In: Taylor RB. Family medicine. New York, NY: Springer-Verlag, 1994.
24. Sanford JP, Gilbert DN, Sande MA. Guide to antimicrobial therapy, 1995. Dallas, Tex: Antimicrobial Therapy, Inc, 1995:24.
25. Boldy DAR, Skidmore SJ, Ayres JG. Acute bronchitis in the community: clinical features, infective factors, changes in pulmonary function and bronchial activity to histamine. Respir Med 1990; 84:377-85.
26. Nelson EC, Kirk JW, Rise BW, et al. The cooperative information project: part 2: some initial clinical, quality assurance, and practice management studies. J Fam Pract 1981; 13:867-76.
27. Hetcher RH, Fletcher SW, Wagner EH. Clinical epidemiology. Baltimore, Md: Williams & Wilkins, 1988:43-75.
28. Grayston JT, Campbell LA, Kuo CC, et al. A new respiratory tract pathogen: Chlamydia pneumoniae, strain TWAR. J Infect Dis 1990; 161:618-25.
29. Grayston JT, Aldons MB, Easton A, et al. Evidence that Chlamydia pneumoniae causes pneumonia and bronchitis. J Infect Dis 1993; 168:1231-5.
30. Thorn DH, Grayston JT, Campbcll LA, et al. Respiratory infection with Chlamydia pneumoniae in middle and older adult outpatients. Eur J Clin Microbiol Infect Dis 1994; 13:785-92.
31. Hueston WJ. Albuterol delivered by metered-dose inhaler to treat acute bronchitis. J Fam Pract 1994; 39:437-40.
32. Drug facts and comparisons. St Louis, Mo: Facts and Comparisons, 1995:343b.
33. Miyatake H, Taki F, Taniguchi H, et al. Erythromycin reduces the severity of bronchial hyperresponsiveness in asthma. Chest 1991; 99:670-3.
34. Banal N, Nahata M. The new macrolide antibiotics: azithromycin, clarithromycin, dirithromycin, and roxithromycin. Ann Pharmacother 1993; 26:46-55.